34.51
Genedx Holdings Corp stock is traded at $34.51, with a volume of 11.11M.
It is down -49.20% in the last 24 hours and down -47.87% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$67.93
Open:
$36.935
24h Volume:
11.11M
Relative Volume:
12.26
Market Cap:
$1.02B
Revenue:
$427.54M
Net Income/Loss:
$-21.02M
P/E Ratio:
-46.51
EPS:
-0.742
Net Cash Flow:
$14.26M
1W Performance:
-47.77%
1M Performance:
-47.87%
6M Performance:
-74.79%
1Y Performance:
-47.84%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
34.51 | 2.02B | 427.54M | -21.02M | 14.26M | -0.742 |
|
TMO
Thermo Fisher Scientific Inc
|
466.76 | 171.91B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
174.63 | 123.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
562.97 | 44.73B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
342.75 | 29.63B | 3.17B | 642.63M | 516.49M | 10.77 |
|
A
Agilent Technologies Inc
|
117.53 | 31.70B | 7.07B | 1.29B | 993.00M | 4.5355 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Cathie Wood’s ARK sells AMD stock, buys Shopify and GeneDx - Investing.com
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth - MSN
WGS stock slumps after hours as firm predicts lower test volume for year - MSN
WGS: GeneDX Shares Plummet Over 45%; Investors Should - GlobeNewswire
Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - ChartMill
GeneDx Stock Crash: WGS Plunges After Guidance Cut Raises Reimbursement Fears - TechStock²
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp. - ChartMill
GeneDx Holdings, Duolingo, Kosmos Energy and other big stocks moving lower in Tuesday's pre-market session - MSN
Genedx Holdings Corp stock hits 52-week low at 36.94 USD - Investing.com
Canaccord cuts GeneDx stock price target on softer revenue outlook - Investing.com
Canaccord cuts GeneDx stock price target on softer revenue outlook By Investing.com - Investing.com Canada
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2026 Earnings Call Transcript - Insider Monkey
GeneDx Holdings Corp. Q1 2026 Financial Results and Forward-Looking Statements – Nasdaq: WGSWW 21 25 27 29 37 39 - Minichart
GeneDx Holdings Corp. Shareholders Are Encouraged to Reach - GlobeNewswire
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Does GeneDx’s Guidance Cut And Core Shift Reshape The Bull Case For GeneDx Holdings (WGS)? - Yahoo Finance
BTIG cuts GeneDx stock price target to $90 on revenue guide cut - Investing.com UK
GeneDx Holdings Corp. (WGS) reports Q1 loss, lags revenue estimates - MSN
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook - BioSpace
GeneDx Q1 2026 slides: volume surges 34% amid revenue headwinds By Investing.com - Investing.com Canada
Will GeneDx Holdings' (WGS) Rising Revenue and Widening Losses Recast Its Profitability Narrative? - simplywall.st
GeneDx Q1 2026 Earnings Call Transcript - MarketBeat
WGS Stock Slumps After Hours As Firm Predicts Lower Test Volume For Year - Stocktwits
Genedx Earnings Call Resets Outlook Amid Strong Growth - TipRanks
GeneDx Holdings Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
GeneDx Q1 Earnings Call Highlights - Yahoo Finance
GeneDx Q1 2026 slides: volume surges 34% amid revenue headwinds - Investing.com
GeneDx (WGS) Q1 2026 Earnings Transcript - AOL.com
WGS: Q1 test volumes rose 34% but revenue missed; guidance cut, focus shifts to core growth and profitability - TradingView
Earnings call transcript: GeneDx Q1 2026 misses earnings, stock rises slightly - Investing.com
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
GeneDx plummets on lower 2026 guidance, Q1 misses - Seeking Alpha
GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall - marketscreener.com
(WGS) GeneDx Now Expects Full Year 2026 Revenue Range $475M$490M, vs. FactSet Est of $550M - marketscreener.com
Earnings Flash (WGS) GeneDx Posts Q1 Revenue $102.3M, vs. FactSet Est of $112.5M - marketscreener.com
GeneDx Holdings Corp (NASDAQ:WGS) Plunges 44% After Disastrous Q1 2026 Miss - ChartMill
GENEDX ($WGS) Releases Q1 2026 Earnings - Quiver Quantitative
GeneDx Holdings Corp. (WGS) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
GeneDx plummets 46% as revenue guidance cut By Investing.com - Investing.com Nigeria
(WGS) GeneDx Holdings Corp. Expects Q2 Revenue Range $110.0M$112.0M - marketscreener.com
GeneDx plummets 46% as revenue guidance cut - Investing.com
Earnings Flash (WGS) GeneDx Holdings Corp. Posts Q1 Adjusted Loss $0.28 per Share - marketscreener.com
GeneDx : Q1 2026 Earnings Presentation PDF - marketscreener.com
GeneDx Holdings (WGS) grows revenue but books $63M loss on impairments - Stock Titan
GeneDx Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GeneDx (Nasdaq: WGS) trims 2026 revenue guidance after Q1 loss widens - Stock Titan
WGS: Q1 2026 delivered strong test volume growth but led to a downward revision in full-year revenue guidance - TradingView
GeneDx (WGS) Q2 2025 Earnings Transcript - The Globe and Mail
Fred Alger Management Highlights GeneDx Holdings Performance in Q1 2026 - HarianBasis.co
Do You Believe in GeneDx Holdings Corp.’s (WGS) Durable Competitive Moat? - Insider Monkey
Jennison Associates LLC Has $39.30 Million Position in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):